Abstract:Right heart catheterization is commonly used to measure right ventricle hemodynamic parameters and is the gold standard for pulmonary arterial hypertension diagnosis; however, it is not suitable for patients' long-term follow-up. Non-invasive echocardiography and nuclear medicine have been applied to measure right ventricle anatomy and function, but the guidelines for the usefulness of clinical parameters remain to be established. The goal of this study is to identify reliable clinical parameters of right ventricle function in pulmonary arterial hypertension patients and analyze the relationship of these clinical parameters with the disease severity of pulmonary arterial hypertension. In this study, 23 normal subjects and 23 pulmonary arterial hypertension patients were recruited from January 2015 to March 2016. Pulmonary arterial hypertension patients were classified into moderate and severe pulmonary arterial hypertension groups according to their mean pulmonary arterial pressure levels. All the subjects were subjected to physical examination, chest X-ray, 12-lead electrocardiogram, right heart catheterization, two-dimensional echocardiography, and technetium 99m (99mTc) myocardial perfusion imaging. Compared to normal subjects, the right heart catheterization indexes including right ventricle systolic pressure, right ventricle end diastolic pressure, pulmonary artery systolic pressure, pulmonary artery diastolic pressure, pulmonary vascular resistance, and right ventricle end systolic pressure increased in pulmonary arterial hypertension patients and were correlated with mean pulmonary arterial pressure levels. Echocardiography parameters, including tricuspid regurgitation peak velocity, tricuspid regurgitation pressure gradient, tricuspid annular plane systolic excursion and fractional area, right ventricle-myocardial performance index, were significantly associated with the mean pulmonary arterial pressure levels in pulmonary arterial hypertension patients. Furthermore, myocardial perfusion imaging was not observed in the normal subjects but in pulmonary arterial hypertension patients, especially severe pulmonary arterial hypertension subgroup, and showed potential diagnostic properties for pulmonary arterial hypertension. In conclusion, mean pulmonary arterial pressure levels are correlated with several right heart catheterization and echocardiography markers in pulmonary arterial hypertension patients; echocardiography and 99mTc myocardial perfusion can be used to evaluate right ventricle performance in pulmonary arterial hypertension patients. Impact statement In this study, we analyzed the clinical parameters for evaluating RV function, including right ventricle catheterization (RHC), echocardiography, and technetium 99m (99mTc) myocardial perfusion imaging (MPI) in normal Asian subjects and PAH patients ( n = 23 for each group). Our results demonstrated that six RHC indexes, four echocardiography indexes and MPI index were significantly altered in PAH patients and correlated with the levels of mean pulmonary arterial pressure. Importantly, we evaluated the diagnostic performance of MPI and found that MPI has a strong diagnostic accuracy in PAH patients. The findings from this study will be of interest to clinical investigators who make diagnosis and therapeutic strategies for PAH patients.

Quantitative Analysis of Lung Perfusion in Patients with Idiopathic Pulmonary Arterial Hypertension

[Diagnostic Value of CT Pulmonary Artery Imaging for Idiopathic Pulmonary Artery Hypertension].

Dynamic Pulmonary Perfusion Imaging in Patients with Idiopathic Pulmonary Arterial Hypertension

[Value of Radionuclide Lung Scintigraphy in the Diagnosis and Quantitative Analysis of Chronic Thromboembolic Pulmonary Hypertension].

Tissue Doppler Imaging Study of Right Ventricular Myocardial Systolic Activation in Subjects with Pulmonary Arterial Hypertension

18F-FDG SPECT Myocardial Imaging of Right Ventricle in Patients with Idiopathic Pulmonary Hypertension

Right ventricle performances with echocardiography and 99mTc myocardial perfusion imaging in pulmonary arterial hypertension patients

Diagnostic efficacy of perfusion scans interpreted by PISA-PED criteria for pulmonary embolism:comparison with CTPA

Semi-quantitative assessment of pulmonary arterial hypertension associated with congenital heart disease through myocardial perfusion imaging

Comparison of Pulmonary Perfusion Imaging with Pulmonary Angiography in Diagnosis of Pulmonary Involvement in Takayasu's Arteritis

Clinical Analysis of 150 Patients with Idiopathic Pulmonary Arterial Hypertension

Correlation Between Quantitative Perfusion Histogram Parameters of DCE-MRI and PTEN, P-Akt and M-Tor in Different Pathological Types of Lung Cancer

Pulmonary lesions: correlative study of dynamic triple-phase enhanced CT perfusion imaging with tumor angiogenesis and vascular endothelial growth factor expression

New Echocardiographic Indexes for Evaluating Cardiac Function in Idiopathic Pulmonary Arterial Hypertension Using Three-Dimensional Echocardiography

Diagnostic Efficacy of Lung Perfusion Scan Interpreted by PISAPED Criteria for Pulmonary Embolism: Comparison with CTPA

Risk Stratification of Patients with Combined Acute Pulmonary Embolism and Pulmonary Hypertension Using Dynamic and Regular Pulmonary Perfusion Imaging

Clinical Significance of Evaluating Pulmonary Hypertension with High Resolution CT Measurement of Pulmonary Vascular Indexes in Chronic Obstructive Pulmonary Disease

Comparison of 18F‐FDG Uptake by Right Ventricular Myocardium in Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated with Congenital Heart Disease

EVALUATION OF PULMONARY HYPERTENSION AND STRATIFICATION OF RISK BY FIRST-PASS RADIONUCLIDE PULMONARY PERFUSION IMAGING IN PATIENTS WITH PULMONARY HYPERTENSION OF ACUTE PULMONARY EMBOLISM

Fractional flow reserve, instantaneous wave-free ratio, and resting Pd/Pa compared with [15O]H2O positron emission tomography myocardial perfusion imaging: a PACIFIC trial sub-study

Low-dose Spectral CT Perfusion Imaging of Lung Cancer Quantitative Analysis in Different Pathological Subtypes.